Rare diseases
Investigational molecules
Locations
Back to Hungary5 clinical trials in Szentes, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on COR-1167 for Patients with Worsening Heart Failure
HungaryStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
HungaryStudy on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors
HungaryStudy of dapagliflozin effects in patients hospitalized with acute heart failure
HungaryStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on Psoriatic Arthritis (PsA) treatments, evaluating novel therapeutic approaches for patients with active disease conditions.
Research includes assessment of innovative medications like deucravacitinib and bimekizumab, specifically designed for patients with varying treatment histories.
Investigation of targeted therapies for autoimmune conditions, with particular emphasis on comparing treatment efficacy against placebo in controlled clinical settings.
Studies focus on both treatment-naïve patients and those with previous exposure to TNFα inhibitors.
Comprehensive research into subcutaneous administration of new therapeutic agents for chronic inflammatory conditions.
Trials aim to establish both immediate and long-term benefits of innovative treatment approaches in inflammatory arthritis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
